Rapid Micro Biosystems (RPID) Cash & Current Investments (2020 - 2026)

Rapid Micro Biosystems has disclosed Cash & Current Investments across 7 years of filings, most recently posting $22.9 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $22.9 million, changed 0.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.9 million (changed 0.37% YoY), and the FY2025 annual result was $18.4 million, down 46.02% from the prior year.
• Cash & Current Investments came in at $22.9 million for Q1 2026 at Rapid Micro Biosystems, up from $18.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $162.2 million in Q1 2022 to a low of $18.4 million in Q4 2025.
• The 5-year median for Cash & Current Investments is $50.7 million (2022), against an average of $63.0 million.
• Across the five-year window, Cash & Current Investments jumped 109.1% in 2023 and sank 71.25% in 2025, its largest moves.
• Rapid Micro Biosystems' Cash & Current Investments stood at $81.8 million in 2022, then increased by 12.56% to $92.1 million in 2023, then tumbled by 63.04% to $34.0 million in 2024, then sank by 46.02% to $18.4 million in 2025, then climbed by 24.95% to $22.9 million in 2026.
• The last three Cash & Current Investments figures came in at $22.9 million (Q1 2026), $18.4 million (Q4 2025), and $41.2 million (Q3 2025), per Business Quant data.